Day One Biopharmaceuticals, Inc. (DAWN)
NASDAQ: DAWN · Real-Time Price · USD
8.70
-0.09 (-1.02%)
Mar 13, 2025, 4:00 PM EST - Market closed
DAWN Employees
Day One Biopharmaceuticals had 181 employees as of December 31, 2024. The number of employees increased by 26 or 16.77% compared to the previous year.
Employees
181
Change (1Y)
26
Growth (1Y)
16.77%
Revenue / Employee
$724,646
Profits / Employee
-$527,602
Market Cap
881.78M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 181 | 26 | 16.77% |
| Dec 31, 2023 | 155 | 34 | 28.10% |
| Dec 31, 2022 | 121 | 66 | 120.00% |
| Dec 31, 2021 | 55 | 35 | 175.00% |
| Dec 31, 2020 | 20 | - | - |
DAWN News
- 16 days ago - Day One Biopharmaceuticals, Inc. (DAWN) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 16 days ago - Day One Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Progress - GlobeNewsWire
- 4 weeks ago - Day One to Report Fourth Quarter and Full-Year 2024 Financial Results Tuesday, February 25, 2025 - GlobeNewsWire
- 2 months ago - Top 5 Commercial Biotech Buyout Candidates: Day One Biopharmaceuticals (No. 5) - Seeking Alpha
- 2 months ago - Day One Biopharmaceuticals: Sales Figures In The Crosshairs - Seeking Alpha
- 3 months ago - Day One to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 4 months ago - Day One Announces Retirement of Dr. Samuel Blackman, Co-Founder and Head of Research & Development - GlobeNewsWire
- 4 months ago - Day One to Participate in the Piper Sandler 36th Annual Healthcare Conference - GlobeNewsWire